Japanese Encephalitis

How do you scale up a vaccine to protect more than 300 million children? We’ve worked for almost two decades with governments, manufacturers, and other partners across Asia and beyond to radically increase protection against Japanese encephalitis, a crippling and incurable disease also known as “brain fever.”

Sept. 20, 2018
How a once little-used vaccine now protects millions from Japanese encephalitis
Case study: India’s leadership in the fight against Japanese encephalitis
Aug. 30, 2019, 1:35 p.m.
Edging out Japanese encephalitis
Our Work
Articles from our global team
17 Articles
17 Articles
17 Articles
  1. Workers manufacturing vaccines
    March 14, 2019

    Supporting vaccine manufacturers to supply critical vaccines

    When more vaccine manufacturers are able to enter the market, supply increases while cost decreases. PATH supports emerging market vaccine manufacturers to do just that, improving access to lifesaving vaccines.
  2. Male hospital pharmacist in Kenya looking at a binder of paperwork. Photo: PATH/Eric Becker.
    January 22, 2019

    A key tool in the race against drug resistance: vaccines

    Drug resistance is one of the biggest threats to global health today. Vaccines can help.
  3. Health center staff with Dr. Mukergee and children standing in front of Japanese Encephalitis poster, West Bengal, India, July 2006
    October 30, 2018

    Japanese encephalitis—no longer neglected: A model for other new vaccines

    No longer neglected? Japanese encephalitis is a model for new vaccines to prevent other tropical diseases.
  4. A girl in Nepal holds her shoulder after she has received her Japanese encephalitis vaccination 22999.jpg
    October 26, 2018

    Four barriers Nepal overcame to introduce Japanese encephalitis vaccines

    Japanese encephalitis was a formidable threat in Nepal, but it was no match for determined and creative decision-makers armed with a safe, effective, and affordable vaccine.
  5. A woman gives a girl an injection as others wait behind her.
    September 20, 2018

    How a once little-used vaccine now protects millions from Japanese encephalitis

    An incurable disease sometimes referred to as “brain fever” once ravaged communities across Asia. But thanks to PATH and our partners, Japanese encephalitis is no longer the threat it once was. A 15-year effort turned a little-known vaccine from China into an internationally approved immunization tool. The vaccine has now reached an estimated 300 million children—a turning point in the battle to protect people from this dreaded disease.
  6. 22915
    July 3, 2018

    How do you protect 300 million children from deadly diseases? Partnerships are key

    On the way to vaccinating 300 million children, PATH forged partnerships from local to global levels to ensure the successful and sustainable launch of Japanese encephalitis vaccine.
Previous
Next